Investors: Peter J. Fromen Sr. Director, Investor Relations 858-202-4507 pfromen@illumina. com or Media: Maurissa Bornstein Public Relations Manager 858-332-4055 mbornstein@illumina. com Illumina currently voiced. ..
Tags: biotech, DNA, DNA Fun, DNA Talks, DNA Tests Defined, General, General DNA, Healthcare Industry, illumina, News, Public Relations, Scientific Instruments
Nov
7
Illumina currently voiced which a Nov 6, 2008 emanate of Nature published sequencing formula of a initial Yoruban tellurian genome.
Tags: biotech, DNA, DNA Fun, DNA Talks, DNA Tests Defined, General, General DNA, Healthcare Industry, illumina, News, Scientific InstrumentsRelated posts
Nov
7
Invitrogen Corporation, a provider of necessary hold up scholarship technologies for investigate, prolongation as well as diagnostics, currently voiced a launch of a initial high-density microarray for a profiling of. ..
Tags: Agilent Technologies, Biology, biotech, DNA, DNA Fun, DNA Talks, DNA Tests Defined, Electronics, General, General DNA, Healthcare Industry, Invitrogen, Medicine, Molecular Biology, News, Programming Languages, SCIENCE, Science / Technology, Scientific Instruments, StartupsRelated posts
Nov
6
Reading DNA: Densely make-up DNA fragments onto this credit-card-size thinly slice from Illumina, called the upsurge dungeon, allows high-throughput sequencing.
Tags: biotech, DNA, DNA Fun, DNA Talks, DNA Tests Defined, General, General DNA, Healthcare Industry, illumina, Medicine, News, Rockville, MD, Scientific InstrumentsRelated posts